Rifaximin
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2125 publications
Enhancement of the solubility and antibacterial performance of rifaximin by loading on chitosan/PEG-functionalized mesoporous silica nanoparticles.
Journal: Journal of materials chemistry. B
Published: September 08, 2026
Refractory Hyperammonemic Encephalopathy as a Paraneoplastic Presentation of Fibrolamellar Hepatocellular Carcinoma: A Case Report.
Journal: The American journal of case reports
Published: August 24, 2026
Reply to "Rifaximin and the DCA-serotonin axis in cirrhotic portal hypertension: how much of the benefit is bile-acid specific?"
Journal: Journal of hepatology
Published: August 17, 2026
Hepatic Encephalopathy in Critical Care.
Journal: Journal of intensive care medicine
Published: August 01, 2026
Non-Fecal Microbiota Transplantation Strategies for Treatment of Recurrent Clostridioides difficile Infection.
Journal: Gastroenterology clinics of North America
Published: July 31, 2026
Correction: Nishimura et al. Rifaximin Attenuates Liver Fibrosis and Hepatocarcinogenesis in a Rat MASH Model by Suppressing the Gut-Liver Axis and Epiregulin-IL-8-Associated Angiogenesis. Int. J. Mol. Sci. 2025, 26, 6710.
Journal: International journal of molecular sciences
Published: July 28, 2026
Microbiome-Gut-Brain Axis in Irritable Bowel Syndrome: Pathophysiology and Therapeutic Approaches
Journal: Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru
Published: July 25, 2026
Hyperammonaemic encephalopathy presenting as a stroke mimic with normal liver function tests.
Journal: BMJ case reports
Published: July 10, 2026
Letter: Interpretation of Cognitive and Clinical Outcomes in the Randomized Trial of Rifaximin for Covert Hepatic Encephalopathy. Authors' Reply.
Journal: Alimentary pharmacology & therapeutics
Published: July 07, 2026
Microbiota dysbiosis and mucosal hyperinnervation contribute to intestinal hyperalgesia in a mouse model of post-infectious irritable bowel syndrome.
Journal: American journal of physiology. Gastrointestinal and liver physiology
Published: June 29, 2026
Letter: Interpretation of Cognitive and Clinical Outcomes in the Randomised Trial of Rifaximin for Covert Hepatic Encephalopathy.
Journal: Alimentary pharmacology & therapeutics
Published: June 28, 2026
Last Updated: 09/26/2026